Live Breaking News & Updates on Biopharmaa Novartis Company

The addition of both Dr. Brenner and Dr. Blouw substantially expands Plus internal expertise in key areas Dr. Brenner will maintain his academic commitments but will greatly contribute to Plus’ scientific and clinical efforts to develop targeted radiotherapeutics for central nervous system (CNS) cancers Dr. Blouw is an expert in CNS tumor biology and in the diagnosis of neoplasms of the cerebrospinal fluid AUSTIN, Texas, April 09, 2024 (GLOBE NEWSWIRE) Plus Therapeutics, Inc. (Nasdaq: PSTV) ( ....

United States , San Diego Division , San Antonio , Sb Kolitz Ctrc Zachry , Corey Davis , Barbara Blouw , Andrew Brenner , March Hedrick , Sanford Burnham Prebys , Utrecht University , Company As Vice , University Of California , Texasam University , San Diego Division Of Biological Sciences , Discovery Institute , Oncology Research , Texas Tech University Health Science Center , Mays Cancer Center , Biopharmaa Novartis Company , College Of American Pathologists Laboratory Accreditation Program , Therapeutics Inc , Ut Health San Antonio , Texasam Health Science Center , Clinical Laboratory Improvement Amendments , Clinical Affairs , Zachry Endowed Chair Neuro Oncology Research ,